Immuneering Corporation (NASDAQ: IMRX)
$1.18
-0.0700 ( -5.60% ) 154.6K
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
Market Data
Open
$1.18
Previous close
$1.25
Volume
154.6K
Market cap
$35.29M
Day range
$1.14 - $1.25
52 week range
$1.05 - $11.06
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 119 | Mar 01, 2024 |
8-k | 8K-related | 16 | Mar 01, 2024 |
4 | Insider transactions | 1 | Feb 09, 2024 |
4 | Insider transactions | 1 | Feb 09, 2024 |
4 | Insider transactions | 1 | Feb 09, 2024 |
4 | Insider transactions | 1 | Feb 09, 2024 |
4 | Insider transactions | 1 | Feb 09, 2024 |
4 | Insider transactions | 1 | Feb 09, 2024 |
8-k | 8K-related | 15 | Feb 02, 2024 |
4 | Insider transactions | 1 | Jan 02, 2024 |